FDA Commissioner Stephen Hahn says the agency is moving at 'lightning speed' on remdesivir but must look at 'the totality of data' before issuing emergency use authorization of the drug.
On 4/30/20 at 11:43 AM EDTAfter optimistic results from a federal trial of Gilead Science's experimental coronavirus drug remdesivir, the U.S. Food and Drug Association is moving at"lightning speed" to review the antiviral drug for COVID-19 treatment, Commissioner Stephen Hahn told Bloomberg.
"There will be a lot of factors that go into all the regulatory decisions," Hahn said,"We want to look at the totality of data to make sure that remdesivir is targeted to the right patients."Oliver Douliery/AFP Although Hahn does not have a projected date for when remdesivir will reach the market, he said the FDA has"several pathways" to allow access.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
People should not rely on results of antibody tests, former FDA commissioner saysAs coronavirus antibody tests become more available to the general public, Dr. Scott Gottlieb, former commissioner of the Food and Drug Administration, tells TODAY: “I don’t think individuals should rely on the results” because “tests on the market now are very variable in quality.” He warns that the tests have “high false positive results” and could make people think are safe from the virus when they are not.
Read more »
U.S. FDA moving with 'lightning speed' on Gilead's COVID-19 drug: BloombergThe U.S. Food and Drug Administration is working at 'lightning speed' to review data on Gilead Sciences Inc's experimental antiviral drug remdesivir in treating COVID-19 disease, the head of the agency told Bloomberg in an interview.
Read more »
FDA says hand sanitizers should be made 'unpalatable' to people to prevent ingestionThe government agency has also urged manufacturers to steer clear of false claims as more than 1,500 companies register to develop hand sanitizers.
Read more »
Could Remdesivir Be the First FDA-Approved Treatment for the Coronavirus?Dr. Fauci and President Trump hope so, based on an NIAID study released Wednesday, though there are reasons to restrain optimism.
Read more »
US FDA may announce emergency use of Gilead's coronavirus drugExperimental drug has proved effective against the new coronavirus in a major study, shortening the time it takes for patients to recover by four days on average, US government and company officials say.
Read more »
Dr. Fauci says remdesivir trial shows drug has promise as FDA plans to announce emergency use'What it has proven is a drug can block this virus,' Fauci said Wednesday while speaking to reporters at the White House.
Read more »